Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Australian competition authority reviewing Ramsay’s acquisition of NCPH from Healthscope

The Australian Competition and Consumer Commission (ACCC) is reviewing the acquisition by Australia’s largest for-profit hospital group, Ramsay Health Care, of Canberra-based National Capital Private Hospital (NCPH), the biggest asset that is being sold off in the liquidation of Healthscope, which was Australia’s second largest hospital group until it went bust last year.

The hottest PE firms in healthcare: Active investors 2015 – 2025

Introduction Healthcare Business International’s inaugural PE Hot List of 50 active private equity firms in healthcare highlights the investors shaping the sector’s future through scale, specialisation and strategic focus. Based on analysis of deal activity, portfolio exposure and sector performance, this offers a snapshot of where capital is now flowing across healthcare services, life sciences […]

India’s Sun Pharma eyes US women’s health pharma company Organon for $10 billion

Sun Pharmaceutical Industries, India’s largest drugmaker by market value and revenue, is reportedly looking to acquire US-based Organon, a company focused on women’s health medicines and devices in a deal that could be worth around $10 billion in enterprise value.  If completed, this would be the largest cross-border acquisition by an Indian pharmaceutical company. 

KKR and GIC struggling to sell Filipino hospital chain Metro Pacific for $3 billion

The sale process for Filipino hospital chain Metro Pacific Hospital Group has stalled due to price misalignment. US private equity firm KKR and Singaporean sovereign wealth fund GIC haven't managed to sell their joint 80% stake at the $3 billion + valuation they were targeting in 2024. The two main interested parties, US private equity firms TPG and Blackstone, think the roughly 20x multiple is far too high. HBI hears one of the bids came in as low as $2 billion.

Australian competition regulator is reviewing GE Healthcare’s Intelerad acquisition

The Australian Competition and Consumer Commission (ACCC) is reviewing the acquisition of medical imaging software company Intelerad by US medtech firm GE Healthcare.  The acquisition of Intelerad by GE from London-based private equity firm Hg Capital was announced in November 2025 in a deal worth $2.3 billion (~€1.97 billion). Hg is completely exiting its majority […]

Hot healthcare private equity firms 2015–2025

This week’s infographic covers healthcare-focused private equity firms by assets under management (AUM), highlighting firms that have made substantial investments in healthcare over 2015-2025.

Find Us